|
1
|
Raj P, Louis XL, Thandapilly SJ, Movahed
A, Zieroth S and Netticadan T: Potential of resveratrol in the
treatment of heart failure. Life Sci. 95:63–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Voduc N, la Porte C, Tessier C, Mallick R
and Cameron DW: Effect of resveratrol on exercise capacity: A
randomized placebo-controlled crossover pilot study. Appl Physiol
Nutr Metab. 39:1183–1187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu RE, Huang WC, Liao CC, Chang YK, Kan NW
and Huang CC: Resveratrol protects against physical fatigue and
improves exercise performance in mice. Molecules. 18:4689–4702.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
|
5
|
Regev-Shoshani G, Shoseyov O, Bilkis I and
Kerem Z: Glycosylation of resveratrol protects it from enzymic
oxidation. Biochem J. 374:157–163. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr
and Walle UK: High absorption but very low bioavailability of oral
resveratrol in humans. Drug Metab Dispos. 32:1377–1382. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: The in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soleas GJ, Yan J and Goldberg DM:
Ultrasensitive assay for three polyphenols (catechin, quercetin and
resveratrol) and their conjugates in biological fluids utilizing
gas chromatography with mass selective detection. J Chromatogr B
Biomed Sci Appl. 757:161–172. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moynihan KA, Grimm AA, Plueger MM,
Bernal-Mizrachi E, Ford E, Cras-Méneur C, Permutt MA and Imai S:
Increased dosage of mammalian Sir2 in pancreatic beta cells
enhances glucose-stimulated insulin secretion in mice. Cell Metab.
2:105–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milne JC, Lambert PD, Schenk S, Carney DP,
Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al: Small
molecule activators of SIRT1 as therapeutics for the treatment of
type 2 diabetes. Nature. 450:712–716. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldberg DM, Yan J and Soleas GJ:
Absorption of three wine-related polyphenols in three different
matrices by healthy subjects. Clin Biochem. 36:79–87. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bertelli AA, Giovannini L, Stradi R,
Bertelli A and Tillement JP: Plasma, urine and tissue levels of
trans- and cis-resveratrol (3,4,5-trihydroxystilbene) after
short-term or prolonged administration of red wine to rats. Int J
Tissue React. 18:67–71. 1996.PubMed/NCBI
|
|
13
|
Aumont V, Krisa S, Battaglia E, Netter P,
Richard T, Mérillon JM, Magdalou J and Sabolovic N: Regioselective
and stereospecific glucuronidation of trans- and cis-resveratrol in
human. Arch Biochem Biophys. 393:281–289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Signorelli P and Ghidoni R: Resveratrol as
an anticancer nutrient: Molecular basis, open questions and
promises. J Nutr Biochem. 16:449–466. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henry-Vitrac C, Desmoulière A, Girard D,
Mérillon JM and Krisa S: Transport, deglycosylation, and metabolism
of trans-piceid by small intestinal epithelial cells. Eur J Nutr.
45:376–382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Juan ME, Vinardell MP and Planas JM: The
daily oral administration of high doses of trans-resveratrol to
rats for 28 days is not harmful. J Nutr. 132:257–260.
2002.PubMed/NCBI
|
|
17
|
Marier JF, Vachon P, Gritsas A, Zhang J,
Moreau JP and Ducharme MP: Metabolism and disposition of
resveratrol in rats: Extent of absorption, glucuronidation, and
enterohepatic recirculation evidenced by a linked-rat model. J
Pharmacol Exp Ther. 302:369–373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asensi M, Medina I, Ortega A, Carretero J,
Baño MC, Obrador E and Estrela JM: Inhibition of cancer growth by
resveratrol is related to its low bioavailability. Free Radic Biol
Med. 33:387–398. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vitrac X, Desmoulière A, Brouillaud B,
Krisa S, Deffieux G, Barthe N, Rosenbaum J and Mérillon JM:
Distribution of [14C]-trans-resveratrol, a cancer chemopreventive
polyphenol, in mouse tissues after oral administration. Life Sci.
72:2219–2233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu C, Shin YG, Chow A, Li Y, Kosmeder JW,
Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG and van Breemen RB:
Human, rat, and mouse metabolism of resveratrol. Pharm Res.
19:1907–1914. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuhnle G, Spencer JP, Chowrimootoo G,
Schroeter H, Debnam ES, Srai SK, Rice-Evans C and Hahn U:
Resveratrol is absorbed in the small intestine as resveratrol
glucuronide. Biochem Biophys Res Commun. 272:212–217. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng X, Maliakal P, Lu H, Lee MJ and Yang
CS: Urinary and plasma levels of resveratrol and quercetin in
humans, mice, and rats after ingestion of pure compounds and grape
juice. J Agric Food Chem. 52:935–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Belguendouz L, Fremont L and Linard A:
Resveratrol inhibits metal ion-dependent and independent
peroxidation of porcine low-density lipoproteins. Biochem
Pharmacol. 53:1347–1355. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jannin B, Menzel M, Berlot JP, Delmas D,
Lançon A and Latruffe N: Transport of resveratrol, a cancer
chemopreventive agent, to cellular targets: Plasmatic protein
binding and cell uptake. Biochem Pharmacol. 68:1113–1118. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Belguendouz L, Frémont L and Gozzelino MT:
Interaction of transresveratrol with plasma lipoproteins. Biochem
Pharmacol. 55:811–816. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Juan ME, Buenafuente J, Casals I and
Planas JM: Plasmatic levels of trans-resveratrol in rats. Food Res
Int. 35:195–199. 2002. View Article : Google Scholar
|
|
27
|
Daviglus ML, Lloyd-Jones DM and Pirzada A:
Preventing cardiovascular disease in the 21st Deweerdt S.
Prevention: Activity is the best medicine. Nature. 475:16–17. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bertram MY, Lim SS, Barendregt JJ and Vos
T: Assessing the cost-effectiveness of drug and lifestyle
intervention following opportunistic screening for pre-diabetes in
primary care. Diabetologia. 53:875–881. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Church T: Exercise in obesity, metabolic
syndrome, and diabetes. Prog Cardiovasc Dis. 53:412–418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deweerdt S: Prevention: Activity is the
best medicine. Nature. 475:S16–S17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hurley BF, Hanson ED and Sheaff AK:
Strength training as a countermeasure to aging muscle and chronic
disease. Sports Med. 41:289–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malaguti M, Angeloni C and Hrelia S:
Polyphenols in exercise performance and prevention of
exercise-induced muscle damage. Oxid Med Cell Longev.
2013:8259282013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji LL, Gomez-Cabrera MC and Vina J: Role
of free radicals and antioxidant signaling in skeletal muscle
health and pathology. Infect Disord Drug Targets. 9:428–444. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dolinsky VW and Dyck JR: Calorie
restriction and resveratrol in cardiovascular health and disease.
Biochim Biophys Acta. 1812:1477–1489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mercken EM, Carboneau BA, Krzysik-Walker
SM and de Cabo R: Of mice and men: The benefits of caloric
restriction, exercise, and mimetics. Ageing Res Rev. 11:390–398.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schrauwen P and Timmers S: Can resveratrol
help to maintain metabolic health? Proc Nutr Soc. 73:271–277. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dolinsky VW, Jones KE, Sidhu RS, Haykowsky
M, Czubryt MP, Gordon T and Dyck JR: Improvements in skeletal
muscle strength and cardiac function induced by resveratrol
contribute to enhanced exercise performance in rats. J Physiol.
590:2783–2799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gliemann L, Schmidt JF, Olesen J, Biensø
RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J,
Pilegaard H, et al: Resveratrol blunts the positive effects of
exercise training on cardiovascular health in aged men. J Physiol.
591:5047–5059. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Olesen J, Gliemann L, Biensø R, Schmidt J,
Hellsten Y and Pilegaard H: Exercise training, but not resveratrol,
improves metabolic and inflammatory status in skeletal muscle of
aged men. J Physiol. 592:1873–1886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Murase T, Haramizu S, Ota N and Hase T:
Suppression of the aging-associated decline in physical performance
by a combination of resveratrol intake and habitual exercise in
senescence-accelerated mice. Biogerontology. 10:423–434. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Baur JA, Pearson KJ, Price NL, Jamieson
HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K,
et al: Resveratrol improves health and survival of mice on a
high-calorie diet. Nature. 444:337–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lagouge M, Argmann C, Gerhart-Hines Z,
Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P,
Elliott P, et al: Resveratrol improves mitochondrial function and
protects against metabolic disease by activating SIRT1 and
PGC-1alpha. Cell. 127:1109–1122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marchal J, Pifferi F and Aujard F:
Resveratrol in mammals: Effects on aging biomarkers, age-related
diseases, and life span. Ann N Y Acad Sci. 1290:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Momken I, Stevens L, Bergouignan A,
Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP,
Sebedio JL, et al: Resveratrol prevents the wasting disorders of
mechanical unloading by acting as a physical exercise mimetic in
the rat. FASEB J. 25:3646–3660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bennet D and Kim S: Effects of agmatine
and resveratrol on RGC-5 cell behavior under light stimulation.
Environ Toxicol Pharmacol. 38:84–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gordon BS, Delgado-Diaz DC, Carson J,
Fayad R, Wilson LB and Kostek MC: Resveratrol improves muscle
function but not oxidative capacity in young mdx mice. Can J
Physiol Pharmacol. 92:243–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hart N, Sarga L, Csende Z, Koltai E, Koch
LG, Britton SL, Davies KJ, Kouretas D, Wessner B and Radak Z:
Resveratrol enhances exercise training responses in rats
selectively bred for high running performance. Food Chem Toxicol.
61:53–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dolinsky VW, Rogan KJ, Sung MM, Zordoky
BN, Haykowsky MJ, Young ME, Jones LW and Dyck JR: Both aerobic
exercise and resveratrol supplementation attenuate
doxorubicin-induced cardiac injury in mice. Am J Physiol Endocrinol
Metab. 305:E243–E253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin CH, Lin CC, Ting WJ, Pai PY, Kuo CH,
Ho TJ, Kuo WW, Chang CH, Huang CY and Lin WT: Resveratrol enhanced
FOXO3 phosphorylation via synergetic activation of SIRT1 and
PI3K/Akt signaling to improve the effects of exercise in elderly
rat hearts. Age (Dordr). 36:97052014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tung BT, Rodríguez-Bies E,
Ballesteros-Simarro M, Motilva V, Navas P and López-Lluch G:
Modulation of endogenous antioxidant activity by resveratrol and
exercise in mouse liver is age dependent. J Gerontol A Biol Sci Med
Sci. 69:398–409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Durbin SM, Jackson JR, Ryan MJ, Gigliotti
JC, Alway SE and Tou JC: Resveratrol supplementation preserves long
bone mass, microstructure, and strength in hindlimb-suspended old
male rats. J Bone Miner Metab. 32:38–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mayers JR, Iliff BW and Swoap SJ:
Resveratrol treatment in mice does not elicit the bradycardia and
hypothermia associated with calorie restriction. FASEB J.
23:1032–1040. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Park HG, Lee YR, Jun JK and Lee WL:
Exercise training is more effective than resveratrol
supplementation on alleviation of inflammation in peritoneal
macrophages of high fat diet mice. J Exerc Nutrition Biochem.
18:79–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jacobs RA and Lundby C: Mitochondria
express enhanced quality as well as quantity in association with
aerobic fitness across recreationally active individuals up to
elite athletes. J Appl Physiol 1985. 114:344–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Holloszy JO and Coyle EF: Adaptations of
skeletal muscle to endurance exercise and their metabolic
consequences. J Appl Physiol Respir Environ Exerc Physiol.
56:831–838. 1984.PubMed/NCBI
|
|
56
|
Biala A, Tauriainen E, Siltanen A, Shi J,
Merasto S, Louhelainen M, Martonen E, Finckenberg P, Muller DN and
Mervaala E: Resveratrol induces mitochondrial biogenesis and
ameliorates Ang II-induced cardiac remodeling in transgenic rats
harboring human renin and angiotensinogen genes. Blood Press.
19:196–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rimbaud S, Ruiz M, Piquereau J, Mateo P,
Fortin D, Veksler V, Garnier A and Ventura-Clapier R: Resveratrol
improves survival, hemodynamics and energetics in a rat model of
hypertension leading to heart failure. PLoS One. 6:e263912011.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Csiszar A, Labinskyy N, Pinto JT, Ballabh
P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, et
al: Resveratrol induces mitochondrial biogenesis in endothelial
cells. Am J Physiol Heart Circ Physiol. 297:H13–H20. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Boudina S, Sena S, O'Neill BT, Tathireddy
P, Young ME and Abel D: Reduced mitochondrial oxidative capacity
and increased mitochondrial uncoupling impair myocardial energetics
in obesity. Circulation. 112:2686–2695. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pierce GN and Dhalla NS: Heart
mitochondrial function in chronic experimental diabetes in rats.
Can J Cardiol. 1:48–54. 1985.PubMed/NCBI
|
|
61
|
Joseph AM, Malamo AG, Silvestre J,
Wawrzyniak N, Carey-Love S, Nguyen LM, Dutta D, Xu J, Leeuwenburgh
C and Adhihetty PJ: Short-term caloric restriction, resveratrol, or
combined treatment regimens initiated in late-life alter
mitochondrial protein expression profiles in a fiber-type specific
manner in aged animals. Exp Gerontol. 48:858–868. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Broskey NT, Greggio C, Boss A, Boutant M,
Dwyer A, Schlueter L, Hans D, Gremion G, Kreis R, Boesch C, et al:
Skeletal muscle mitochondria in the elderly: Effects of physical
fitness and exercise training. J Clin Endocrinol Metab.
99:1852–1861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Laupheimer MW, Perry M, Benton S,
Malliaras P and Maffulli N: Resveratrol exerts no effect on
inflammatory response and delayed onset muscle soreness after a
marathon in male athletes.: A randomised, double-blind,
placebo-controlled pilot feasibility study. Transl Med UniSa.
10:38–42. 2014.PubMed/NCBI
|
|
64
|
Scribbans TD, Ma JK, Edgett BA, Vorobej
KA, Mitchell AS, Zelt JG, Simpson CA, Quadrilatero J and Gurd BJ:
Resveratrol supplementation does not augment performance
adaptations or fibre-type-specific responses to high-intensity
interval training in humans. Appl Physiol Nutr Metab. 39:1305–1313.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dal-Ros S, Zoll J, Lang AL, Auger C,
Keller N, Bronner C, Geny B and Schini-Kerth VB: Chronic intake of
red wine polyphenols by young rats prevents aging-induced
endothelial dysfunction and decline in physical performance: Role
of NADPH oxidase. Biochem Biophys Res Commun. 404:743–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
McAnulty LS, Miller LE, Hosick PA, Utter
AC, Quindry JC and McAnulty SR: Effect of resveratrol and quercetin
supplementation on redox status and inflammation after exercise.
Appl Physiol Nutr Metab. 38:760–765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Radak Z, Chung HY, Koltai E, Taylor AW and
Goto S: Exercise, oxidative stress and hormesis. Ageing Res Rev.
7:34–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
de Moraes C, Davel AP, Rossoni LV, Antunes
E and Zanesco A: Exercise training improves relaxation response and
SOD-1 expression in aortic and mesenteric rings from high caloric
diet-fed rats. BMC Physiol. 8:122008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Gu Q, Wang B, Zhang XF, Ma YP, Liu JD and
Wang XZ: Chronic aerobic exercise training attenuates aortic
stiffening and endothelial dysfunction through preserving aortic
mitochondrial function in aged rats. Exp Gerontol. 56:37–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Spanier G, Xu H, Xia N, Tobias S, Deng S,
Wojnowski L, Forstermann U and Li H: Resveratrol reduces
endothelial oxidative stress by modulating the gene expression of
superoxidedismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and
NADPH oxidase subunit (Nox4). J Physiol Pharmacol. 60:111–116.
2009.PubMed/NCBI
|
|
71
|
Ungvari Z, Orosz Z, Rivera A, Labinskyy N,
Xiangmin Z, Olson S, Podlutsky A and Csiszar A: Resveratrol
increases vascular oxidative stress resistance. Am J Physiol Heart
Circ Physiol. 292:H2417–H2424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Carrizzo A, Puca A, Damato A, Marino M,
Franco E, Pompeo F, Traficante A, Civitillo F, Santini L, Trimarco
V, et al: Resveratrol improves vascular function in patients with
hypertension and dyslipidemia by modulating NO metabolism.
Hypertension. 62:359–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Soylemez S, Sepici A and Akar F:
Resveratrol supplementation gender independently improves
endothelial reactivity and suppresses superoxide production in
healthy rats. Cardiovasc Drugs Ther. 23:449–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kao CL, Chen LK, Chang YL, Yung MC, Hsu
CC, Chen YC, Lo WL, Chen SJ, Ku HH and Hwang SJ: Resveratrol
protects human endothelium from H(2)O(2)-induced oxidative stress
and senescence via SirT1 activation. J Atheroscler Thromb.
17:970–979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ungvari Z, Labinskyy N, Mukhopadhyay P,
Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P and Csiszar A:
Resveratrol attenuates mitochondrial oxidative stress in coronary
arterial endothelial cells. Am J Physiol Heart Circ Physiol.
297:H1876–H1881. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Mittleman MA, Maclure M, Tofler GH,
Sherwood JB, Goldberg RJ and Muller JE: Determinants of Myocardial
Infarction Onset Study Investigators: Triggering of acute
myocardial infarction by heavy physical exertion. Protection
against triggering by regular exertion. N Engl J Med.
329:1677–1683. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Willich SN, Lewis M, Löwel H, Arntz HR,
Schubert F and Schröder R: Triggers and Mechanisms of Myocardial
Infarction Study Group: Physical exertion as a trigger of acute
myocardial infarction. N Engl J Med. 329:1684–1690. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yamashita N, Hoshida S, Otsu K, Asahi M,
Kuzuya T and Hori M: Exercise provides direct biphasic
cardioprotection via manganese superoxide dismutase activation. J
Exp Med. 189:1699–1706. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kaga S, Zhan L, Matsumoto M and Maulik N:
Resveratrol enhances neovascularization in the infarcted rat
myocardium through the induction of thioredoxin-1, heme oxygenase-1
and vascular endothelial growth factor. J Mol Cell Cardiol.
39:813–822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Hung LM, Su MJ and Chen JK: Resveratrol
protects myocardial ischemia-reperfusion injury through both
NO-dependent and NO-independent mechanisms. Free Radic Biol Med.
36:774–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hwang JT, Kwon DY, Park OJ and Kim MS:
Resveratrol protects ROS-induced cell death by activating AMPK in
H9c2 cardiac muscle cells. Genes Nutr. 2:323–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ray PS, Maulik G, Cordis GA, Bertelli AA,
Bertelli A and Das DK: The red wine antioxidant resveratrol
protects isolated rat hearts from ischemia reperfusion injury. Free
Radic Biol Med. 27:160–169. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Goh SS, Woodman OL, Pepe S, Cao AH, Qin C
and Ritchie RH: The red wine antioxidant resveratrol prevents
cardiomyocyte injury following ischemia-reperfusion via multiple
sites and mechanisms. Antioxid Redox Signal. 9:101–113. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shen M, Wu RX, Zhao L, Li J, Guo HT, Fan
R, Cui Y, Wang YM, Yue SQ and Pei JM: Resveratrol attenuates
ischemia/reperfusion injury in neonatal cardiomyocytes and its
underlying mechanism. PLoS One. 7:e512232012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Duran MO, Baltaci AK, Mogulkoc R, Avunduk
MC and Ergene N: The effect of resveratrol supplementation on
plasma leptin and liver glycogen levels in rats with acute swimming
exercise. Acta Physiol (Oxf). 215(Suppl 705): 87. 2015.
|
|
86
|
Arslangil D: The effect of resveratrol
supplementation on element metabolism in blood and some tissue of
rats with acute swimming exercise. Republic of Turkey Selcuk
University Health Sciences Institute Master Thesis2010
|
